Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by oilcan2012on Aug 01, 2017 10:16am
643 Views
Post# 26532982

RE:RE:Soon...

RE:RE:Soon...You might want to evaluate the entire scope of Aurora's investments, such as RTI, CANN, HEMPCO and Pedanios. If ACB's market was contained to just Canada, your analysis is reasonable. Pedanios for example, is executing upon a strategy that encompasses the EU, ~502 million people potential. How many Aurora SKY's could be established to supply that?  

The next couple of years will see us better understand how this will benefit shareholders. That said, I am confident that SP will rise to be in the double digits as ACB continues to execute as they have. 




MeAndMyTwoCents wrote: While I don't want to disagree with you, nor do I want to open up a "valuation argument", the only thing that worries me a little about ACB vs. the other LP's is their dilution. with ~370 millions shares outstanding, they will have to absolutely dominate a large part of multiple markets for this stock to hit the kinds of prices some people are dreaming about (myself included). If we take the middle ground of a 3-5 revenue multiple (which I have been told is fair for growth stocks), if ACB sells their entire 100,000 KG's at $6 per gram on average (once Aurora Sky is fully operational), that's revenue of $600M, which would equate to a $2.4B market cap using the middel ground of 4 x revenue. Even at $2.4B, that only equates to a $6.50 share price at this float size. I realize that only using revenue is not a complete analysis, and I also recognize that ACB may have other revenue streams over and above this (?), but my point is that the company will have to be absolutely huge to get this stock anywhere near $10 share. For those wishing to get "stupid rich" off this stock, you will have to start with a very large investment in a lot of shares. I welcome any additions or criticisms to this.


Bullboard Posts